Patents by Inventor William G. Weisburg

William G. Weisburg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5466577
    Abstract: Nucleic acid probes are described for detecting bacteria capable of causing Lyme disease. These probes complement the ribosomal ribonucleic acid sequences unique to Borrelia spirochetes, and as such can detect the rRNA, rDNA, or polymerase chain reaction amplification products of these genes. These probes, plus the described amplification primers, can be used to detect the etiological agent of Lyme disease in human or veterinary samples, and for determining the infective potential of Ixodes ticks.
    Type: Grant
    Filed: October 27, 1993
    Date of Patent: November 14, 1995
    Assignee: Amoco Corporation
    Inventor: William G. Weisburg
  • Patent number: 5464743
    Abstract: Nucleic acid probes are described for detecting yeasts capable of causing cryptococcosis, specifically Cryptococcus neoformans. The preferred probes are complementary to the ribosomal ribonucleic acid sequences unique to Cryptococcus neoformans, and as such can detect the rRNA, rDNA, or polymerase chain reaction amplification products of these genes. The detection of the etiological agent of human cryptococcosis, and tests for making a clinical diagnosis of this disease utilizing specific rRNA or rDNA probes are now possible.
    Type: Grant
    Filed: July 1, 1992
    Date of Patent: November 7, 1995
    Assignee: Amoco Corporation
    Inventors: William G. Weisburg, Susan M. Barns
  • Patent number: 5403710
    Abstract: Nucleic acid probes are described for detecting yeasts capable of causing Candida infection, specifically yeasts of the genera Candida, Torulopsis, and Yarrowia. The preferred probes are complementary to ribonucleic acid sequences unique to specific Candida species, or groups of such species, and as such can detect the rRNA, rDNA, or polymerase chain reaction amplification products of these genes. Methods for detecting the etiological agent of human Candida fungemia utilizing these probes are also provided.
    Type: Grant
    Filed: June 11, 1993
    Date of Patent: April 4, 1995
    Assignee: Amoco Corporation
    Inventors: William G. Weisburg, Susan M. Barns, David J. Lane, Jeffrey F. Lemontt
  • Patent number: 5401631
    Abstract: Nucleic acid probes capable of hybridizing to rRNA of eubacteria and not to rRNA of non-eubacteria are described along with methods utilizing such probes for the detection of eubacteria in clinical and other samples. Preferred embodiments include probes capable of distinguishing between gram-positive and gram-negative bacteria.
    Type: Grant
    Filed: September 27, 1991
    Date of Patent: March 28, 1995
    Assignee: Amoco Corporation
    Inventors: David J. Lane, Jyotsna Shah, Amelia Buharin, William G. Weisburg
  • Patent number: 5324632
    Abstract: Nucleic acid probes are described for detecting fungi capable of causing fungal septicemia or capable of causing food spoilage. The preferred probes are complementary to ribonucleic acid sequences found in numerous fungi and absent in animal or plant genomes. As such, these probes can detect the rRNA, rDNA, or polymerase chain reaction amplification products from the majority of fungal species. The detection of etiological agents of human fungemia, the clinical diagnosis of this disease and the direct evaluation of food or beverage fungal content utilizing rRNA or rDNA probes is now possible.
    Type: Grant
    Filed: October 22, 1991
    Date of Patent: June 28, 1994
    Assignee: Amoco Corporation
    Inventors: William G. Weisburg, Susan M. Barns, Dale A. Pelletier, Mitchell L. Sogin